The hERG K+ channel: target and antitarget strategies in drug development.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Pharmacological Research

• Publication date

  2008-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.phrs.2008.01.009PMID 18329284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety Pharmacology Society

  2010cited by this paper
• Coexistence of hERG current block and disruption of protein trafficking in ketoconazole‐induced long QT syndrome

  2008cited by this paper
• Doxazosin induces apoptosis of cells expressing hERG K+ channels.

  2008cited by this paper
• 2-[2-(3,4-Dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic Acid (PD-307243) Causes Instantaneous Current through Human Ether-a-go-go-Related Gene Potassium Channels

  2008cited by this paper
• Choice of cardiac tissue in vitro plays an important role in assessing the risk of drug-induced cardiac arrhythmias in human: beyond QT prolongation.

  2008cited by this paper
• Overexpression of hERG1 in resected esophageal squamous cell carcinomas: A marker for poor prognosis

  2008cited by this paper
• Alfuzosin Delays Cardiac Repolarization by a Novel Mechanism

  2008cited by this paper
• HERG Is Protected from Pharmacological Block by α-1,2-Glucosyltransferase Function*

  2007cited by this paper
• Dispersion of repolarization in canine ventricle and the electrocardiographic T wave: Tp-e interval does not reflect transmural dispersion.

  2007cited by this paper
• ERG Conductance Expression Modulates the Excitability of Ventral Horn GABAergic Interneurons That Control Rhythmic Oscillations in the Developing Mouse Spinal Cord

  2007cited by this paper
• Safety pharmacology and prolongation of the QT interval

  2007cited by this paper
• Temporal development of asymmetric reward-induced bias in macaques.

  2007cited by this paper
• Orange flavonoid hesperetin modulates cardiac hERG potassium channel via binding to amino acid F656.

  2007cited by this paper
• Toxins interacting with ether-à-go-go-related gene voltage-dependent potassium channels.

  2007cited by this paper
• Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac Death

  2007cited by this paper
• VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome.

  2007cited by this paper
• Cardiac Glycosides as Novel Inhibitors of Human Ether-a-go-go-Related Gene Channel Trafficking

  2007cited by this paper
• Proarrhythmia as a Class Effect of Quinolones: Increased Dispersion of Repolarization and Triangulation of Action Potential Predict Torsades de Pointes

  2007cited by this paper
• The Additive Effects of the Active Component of Grapefruit Juice (Naringenin) and Antiarrhythmic Drugs on HERG Inhibition

  2007cited by this paper
• Reduction of Dispersion of Repolarization and Prolongation of Postrepolarization Refractoriness Explain the Antiarrhythmic Effects of Quinidine in a Model of Short QT Syndrome

  2007cited by this paper
• Computational model predicts a role for ERG current in repolarizing plateau potentials in dopamine neurons: implications for modulation of neuronal activity.

  2007cited by this paper
• Identification of IKr and Its Trafficking Disruption Induced by Probucol in Cultured Neonatal Rat Cardiomyocytes

  2007cited by this paper
• The S631A mutation causes a mechanistic switch in the block of hERG channels by CnErg1.

  2007cited by this paper
• Mechanism of block of the hERG K+ channel by the scorpion toxin CnErg1.

  2007cited by this paper
• Drug-induced long QT and torsade de pointes: recent advances

  2007cited by this paper
• APETx1 from Sea Anemone Anthopleura elegantissima Is a Gating Modifier Peptide Toxin of the Human Ether-a-go-go- Related Potassium Channel

  2007cited by this paper
• L‐Type Calcium Current Reactivation Contributes to Arrhythmogenesis Associated with Action Potential Triangulation

  2007cited by this paper
• Green tea flavonoid epigallocatechin-3-gallate (EGCG) inhibits cardiac hERG potassium channels.

  2007cited by this paper
• In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.

  2007cited by this paper
• HERG is protected from pharmacological block by alpha-1,2-glucosyltransferase function.

  2007cited by this paper
• Combined hERG channel inhibition and disruption of trafficking in drug‐induced long QT syndrome by fluoxetine: a case‐study in cardiac safety pharmacology

  2006cited by this paper
• Mallotoxin Is a Novel Human Ether-a-go-go-Related Gene (hERG) Potassium Channel Activator

  2006cited by this paper
• Ether à go-go potassium channels and cancer.

  2006cited by this paper
• Ether-a-go-go-related gene potassium channels: what's all the buzz about?

  2006cited by this paper
• Moving towards better predictors of drug-induced Torsade de Pointes

  2006cited by this paper
• Species Diversity and Peptide Toxins Blocking Selectivity of Ether-à-go-go-Related Gene Subfamily K+ Channels in the Central Nervous System

  2006cited by this paper
• Thorough QT/QTc Not So Thorough: Removes Torsadogenic Predictors from the T‐Wave, Incriminates Safe Drugs, and Misses Profibrillatory Drugs

  2006cited by this paper
• Muscarinic Regulation of Ether-a-go-go-Related Gene K+ Currents in Interstitial Cells of Cajal

  2006cited by this paper
• Can pharmacogenetics help rescue drugs withdrawn from the market?

  2006cited by this paper
• Characterization of depolarization‐evoked ERG K+ currents in interstitial cells of Cajal

  2006cited by this paper
• In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.

  2006cited by this paper
• Evaluation of the Rabbit Purkinje Fibre Assay as an in vitro Tool for Assessing the Risk of Drug-Induced Torsades de Pointes in Humans

  2006cited by this paper
• Calmodulin Antagonist W‐7 Prevents Sparfloxacin‐Induced Early Afterdepolarizations (EADs) in Isolated Rabbit Purkinje Fibers: Importance of Beat‐to‐Beat Instability of the Repolarization

  2006cited by this paper
• The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.

  2006cited by this paper
• Activation of Human ether-a-go-go-Related Gene Potassium Channels by the Diphenylurea 1,3-Bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643)

  2006cited by this paper
• Safety Pharmacology Society: 5th Annual Meeting

  2006cited by this paper
• Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome.

  2006cited by this paper
• ILSI-HESI cardiovascular safety subcommittee initiative: evaluation of three non-clinical models of QT prolongation.

  2006cited by this paper
• Most LQT2 Mutations Reduce Kv11.1 (hERG) Current by a Class 2 (Trafficking-Deficient) Mechanism

  2006cited by this paper
• hERG1 channels in human esophagus: Evidence for their aberrant expression in the malignant progression of Barrett's esophagus

  2006cited by this paper
• Mechanism of Action of a Novel Human ether-a-go-go-Related Gene Channel Activator

  2006cited by this paper
• Drug‐induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine

  2006cited by this paper
• Comparative Evaluation of HERG Currents and QT Intervals following Challenge with Suspected Torsadogenic and Nontorsadogenic Drugs

  2006cited by this paper
• Short QT syndrome: clinical findings and diagnostic-therapeutic implications.

  2006cited by this paper
• Biophysical Characterization of the New Human Ether-A-Go-Go-Related Gene Channel Opener NS3623 [N-(4-Bromo-2-(1H-tetrazol-5-yl)-phenyl)-N′-(3′-trifluoromethylphenyl)urea]

  2006cited by this paper
• International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels

  2005cited by this paper
• hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines

  2005cited by this paper
• Pentamidine-Induced Long QT Syndrome and Block of hERG Trafficking

  2005cited by this paper
• A Novel Form of Short QT Syndrome (SQT3) Is Caused by a Mutation in the KCNJ2 Gene

  2005cited by this paper
• International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium Channels

  2005cited by this paper
• The use of electrocardiograms in clinical trials: a public discussion of the proposed ICH E14 regulatory guidance

  2005cited by this paper
• Drugs, QTc Interval Prolongation and Final ICH E14 Guideline

  2005cited by this paper
• QTc Prolongation by Grapefruit Juice and Its Potential Pharmacological Basis: HERG Channel Blockade by Flavonoids

  2005cited by this paper
• Pentamidine reduces hERG expression to prolong the QT interval

  2005cited by this paper
• Interneurons transiently express the ERG K+ channels during development of mouse spinal networks in vitro.

  2005cited by this paper
• The Mechanism of Pause‐Induced Torsade de Pointes in Long QT Syndrome

  2005cited by this paper
• New Mechanism Contributing to Drug-Induced Arrhythmia: Rescue of a Misprocessed LQT3 Mutant

  2005cited by this paper
• Local Anesthetic Interaction with Human Ether-a-go-go–related Gene (HERG) Channels: Role of Aromatic Amino Acids Y652 and F656

  2005cited by this paper
• Refining detection of drug-induced proarrhythmia: QT interval and TRIaD.

  2005cited by this paper
• {Omega}-3 and {omega}-6 polyunsaturated fatty acids block HERG channels.

  2005cited by this paper
• Further Insights into the Effect of Quinidine in Short QT Syndrome Caused by a Mutation in HERG

  2005cited by this paper
• Clinical characteristics and treatment of short QT syndrome

  2005cited by this paper
• Novel Potent Human Ether-à-Go-Go-Related Gene (hERG) Potassium Channel Enhancers and Their in Vitro Antiarrhythmic Activity

  2005cited by this paper
• QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development

  2005cited by this paper
• Discovery of a Small Molecule Activator of the Human Ether-a-go-go-Related Gene (HERG) Cardiac K+ Channel

  2005cited by this paper
• ICH S7B draft guideline on the non-clinical strategy for testing delayed cardiac repolarisation risk of drugs: a critical analysis

  2005cited by this paper
• HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin

  2005cited by this paper
• The potent inhibitory effects of cisapride, a specific blocker for human ether-a-go-go-related gene (HERG) channel, on gastric cancer cells

  2005cited by this paper
• Drugs, QT Interval Prolongation and ICH E14

  2005cited by this paper
• Blockade of HERG channels by HIV protease inhibitors.

  2005cited by this paper
• HERG-Lite: a novel comprehensive high-throughput screen for drug-induced hERG risk.

  2005cited by this paper
• ICH E14: A New Regulatory Guidance on the Clinical Evaluation of QT/QTc Internal Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs

  2005cited by this paper
• Amplified Transmural Dispersion of Repolarization as the Basis for Arrhythmogenesis in a Canine Ventricular-Wedge Model of Short-QT Syndrome

  2004influential reference
• Sensitivity and specificity of isolated perfused guinea pig heart to test for drug-induced lengthening of QTc.

  2004cited by this paper
• Roles of K+ channels in regulating tumour cell proliferation and apoptosis

  2004cited by this paper
• Ether à go-go Potassium Channels as Human Cervical Cancer Markers

  2004cited by this paper
• Short QT syndrome: pharmacological treatment.

  2004cited by this paper
• Mechanisms of arsenic-induced prolongation of cardiac repolarization.

  2004cited by this paper
• Expression of ether à go-go potassium channels in human gliomas.

  2004cited by this paper
• Pharmacology of cardiac potassium channels.

  2004cited by this paper
• herg1 Gene and HERG1 Protein Are Overexpressed in Colorectal Cancers and Regulate Cell Invasion of Tumor Cells

  2004cited by this paper
• Mutation in the KCNQ1 Gene Leading to the Short QT-Interval Syndrome

  2004cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Cloning and Functional Characterization of the Smooth Muscle Ether-a-go-go-related Gene K+ Channel

  2003cited by this paper
• Thapsigargin Selectively Rescues the Trafficking Defective LQT2 Channels G601S and F805C*

  2003cited by this paper
• T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity.

  2003cited by this paper
• ERG K+ currents regulate pacemaker activity in ICC.

  2003influential reference
• ERG K+ channels modulate the electrical and contractile activities of gallbladder smooth muscle.

  2003cited by this paper
• Expression and function of KCNH2 (HERG) in the human jejunum.

  2003cited by this paper
• Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG

  2003influential reference

• ELISA protein detector (EPD): A Python-based ELISA tool for accurate low-level protein quantification.

  2025cites this paper
• Binding interaction of acetylcholinesterase with steroidal pregnanes: insight from machine learning and atomistic simulation.

  2025cites this paper
• Toxicity of ACP-105: a substance used as doping in sports: application of in silico methods for prediction of selected toxicological endpoints

  2025cites this paper
• Machine learning-based QSAR and molecular modeling identify promising PTP1B modulators from Ocimum gratissimum for type 2 diabetes therapy.

  2025cites this paper
• Halogenated Curcumin Derivatives: SwissADME/ADMT, DFT and Biological Targets Prediction

  2025cites this paper
• The Developmental Toxicity of Haloperidol on Zebrafish (Danio rerio) Embryos

  2025cites this paper
• Pharmacophore-Based Virtual Screening of Alkaloids and Flavonoids for Designing Drugs with Inhibitory Activity on the Enzyme Monoamine Oxidase B

  2025cites this paper
• hERG activators exhibit antitumor effects in breast cancer through calcineurin and β-catenin-mediated signaling pathways

  2025cites this paper
• The search for the holy grail: In silico design and analysis of a non-sedative third generation, cetirizine-derived H1R anti-histamine with reduced hERG toxicity

  2025cites this paper
• Concurrent Optimizations of Efficacy and Blood-Brain Barrier Permeability in New Macrocyclic LRRK2 Inhibitors for Potential Parkinson's Disease Therapeutics.

  2024cites this paper
• The Benzoylpiperidine Fragment as a Privileged Structure in Medicinal Chemistry: A Comprehensive Review

  2024cites this paper
• Investigation of the Effect of Tamoxifen on hERG1 Potassium Channel Gene Expression in MCF-7 Cell Line

  2024cites this paper
• Effects of plant extracts and derivatives on cardiac K+, Nav, and Cav channels: a review

  2024cites this paper
• Predicting Cardiotoxicity of Molecules Using Attention-Based Graph Neural Networks

  2024cites this paper
• Targeting the hERG1 and β1 integrin complex for cancer treatment

  2024cites this paper
• Computer-Aided Drug Discovery and Design: Recent Advances and Future Prospects.

  2024cites this paper
• Derivation of Highly Predictive 3D-QSAR Models for hERG Channel Blockers Based on the Quantum Artificial Neural Network Algorithm

  2023cites this paper
• Can We Quickly Learn to "Translate" Bioactive Molecules with Transformer Models?

  2023cites this paper
• Multiscale mapping of transcriptomic signatures for cardiotoxic drugs

  2023cites this paper
• Mitigating hERG Liability of Toll‐Like Receptor 9 and 7 Antagonists through Structure‐Based Design

  2023cites this paper
• Evaluation of Some Safety Parameters of Dual Histamine H3 and Sigma-2 Receptor Ligands with Anti-Obesity Potential

  2023cites this paper
• Identification of neurotherapeutic constituents in Ocimum gratissimum with cholinesterase and mono amine oxidase inhibitory activities, using GC-MS analysis, in vitro, and in silico approaches

  2023cites this paper
• GC-MS chemical profiling, antioxidant, anti-diabetic, and anti-inflammatory activities of ethyl acetate fraction of Spilanthes filicaulis (Schumach. and Thonn.) C.D. Adams leaves: experimental and computational studies

  2023cites this paper
• Profiling the antidiabetic potential of GC–MS compounds identified from the methanolic extract of Spilanthes filicaulis: experimental and computational insight

  2023cites this paper
• Facilitation of hERG Activation by Its Blocker: A Mechanism to Reduce Drug-Induced Proarrhythmic Risk

  2023cites this paper
• Therapeutic Study of Cinnamic Acid Derivative for Oxidative Stress Ablation: The Computational and Experimental Answers

  2023cites this paper
• Probing the multitargeting potential of n-hexane fraction of Gongronema latifolium leaves in neurodegeneration via in vitro, GC–MS and in silico studies

  2023cites this paper
• A Review of Computational Methods in Predicting hERG Channel Blockers

  2022cites this paper
• Toward Quantitative Models in Safety Assessment: A Case Study to Show Impact of Dose–Response Inference on hERG Inhibition Models

  2022cites this paper
• Pharmacoinformatic study of inhibitory potentials of selected flavonoids against papain-like protease and 3-chymotrypsin-like protease of SARS-CoV-2

  2022cites this paper
• Structural and Biofunctional Insights into the Cyclo(Pro-Pro-Phe-Phe-) Scaffold from Experimental and In Silico Studies: Melanoma and Beyond

  2022cites this paper
• Antimalarial phytochemicals as potential inhibitors of SARS-CoV-2 guanine N7-methyltransferase (nsp 14): an integrated computational approach

  2022cites this paper
• Identification of promising multi-targeting inhibitors of obesity from Vernonia amygdalina through computational analysis

  2022cites this paper
• A Comprehensive In Silico Exploration of Pharmacological Properties, Bioactivities, Molecular Docking, and Anticancer Potential of Vieloplain F from Xylopia vielana Targeting B-Raf Kinase

  2022cites this paper
• Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum

  2021cites this paper
• Dual targeting of cytokine storm and viral replication in COVID-19 by plant-derived steroidal pregnanes: An in silico perspective

  2021cites this paper
• Stress Driven Discovery of Natural Products From Actinobacteria with Anti-Oxidant and Cytotoxic Activities Including Docking and ADMET Properties

  2021cites this paper
• Mechanism and prevention strategy of a bidirectional relationship between heart failure and cancer (Review)

  2021cites this paper
• The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia

  2021cites this paper
• Effective Perturbations on the Amplitude and Hysteresis of Erg-Mediated Potassium Current Caused by 1-Octylnonyl 8-[(2-hydroxyethyl)[6-oxo-6(undecyloxy)hexyl]amino]-octanoate (SM-102), a Cationic Lipid

  2021cites this paper
• Computational Exploration of Anti-Cancer Potential of Guaiane Dimers from Xylopia vielana by Targeting B-Raf Kinase Using Chemo-Informatics, Molecular Docking and MD Simulation Studies.

  2021cites this paper
• Prediction of hERG inhibition of drug discovery compounds using biomimetic HPLC measurements

  2021cites this paper
• Dual targeting of cytokine storm and viral replication in COVID-19 by plant-derived steroidal pregnanes in silico

  2021cites this paper
• NBD-Based Environment-Sensitive Fluorescent Probes for the Human Ether-a-Go-Go–Related Gene Potassium Channel

  2021cites this paper
• Synthesis, Antitumor Activity and Molecular Docking Studies on Seven Novel Thiazacridine Derivatives.

  2020cites this paper
• Critical Assessment of Artificial Intelligence Methods for Prediction of hERG Channel Inhibition in the "Big Data" Era

  2020cites this paper
• KV11.1, NaV1.5, and CaV1.2 Transporter Proteins as Antitarget for Drug Cardiotoxicity

  2020cites this paper
• Characterization of the Synergistic Inhibition of IK(erg) and IK(DR) by Ribociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor

  2020cites this paper
• The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia

  2020cites this paper
• A comprehensive in silico exploration of pharmacological properties, bioactivities and COX-2 inhibitory potential of eleutheroside B from Eleutherococcus senticosus (Rupr. & Maxim.) Maxim.

  2020cites this paper
• Prediction of hERG potassium channel blockage using ensemble learning methods and molecular fingerprints.

  2020cites this paper
• Characterization of Convergent Suppression by UCL-2077 (3-(Triphenylmethylaminomethyl)pyridine), Known to Inhibit Slow Afterhyperpolarization, of erg-Mediated Potassium Currents and Intermediate-Conductance Calcium-Activated Potassium Channels

  2020cites this paper
• Deep Learning-Based Prediction of Drug-Induced Cardiotoxicity

  2019cites this paper
• Molecular Docking Guided Grid-Independent Descriptor Analysis to Probe the Impact of Water Molecules on Conformational Changes of hERG Inhibitors in Drug Trapping Phenomenon

  2019cites this paper
• Probucol-induced hERG Channel Reduction can be Rescued by Matrine and Oxymatrine in vitro

  2019cites this paper
• Relative positioning of Kv11.1 (hERG) K+ channel cytoplasmic domain-located fluorescent tags toward the plasma membrane

  2018cites this paper
• Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging

  2018cites this paper
• Computer-Aided Drug Design: An Overview.

  2018cites this paper
• Investigating the state dependence of drug binding in hERG channels using a trapped-open channel phenotype

  2018cites this paper
• ECoFFeS: A Software Using Evolutionary Computation for Feature Selection in Drug Discovery

  2018cites this paper
• Experimentally Validated Pharmacoinformatics Approach to Predict hERG Inhibition Potential of New Chemical Entities

  2018cites this paper
• Towards a Structural View of Drug Binding to hERG K+ Channels.

  2017cites this paper
• Characterization and structure‐activity relationship of natural flavonoids as hERG K+ channel modulators

  2017cites this paper
• Balancing the Need for Personalization of QT Correction and Generalization of Study Results: Going Beyond Thorough QT Studies

  2017cites this paper
• Ion currents of cardiomyocytes in different regions of the Göttingen minipig heart.

  2017cites this paper
• Natural products modulating the hERG channel: heartaches and hope† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7np00014f

  2017cites this paper
• EVERY STEP OF THE WAY The Comprehensive In Vitro Proarrhythmia Assay ( CiPA ) Guide : A New Approach to Cardiac Risk Assessment

  2016cites this paper
• 1 hERG channels : from antitargets to novel targets for cancer therapy

  2016cites this paper
• Astemizole Derivatives as Fluorescent Probes for hERG Potassium Channel Imaging.

  2016cites this paper
• Acepromazine inhibits hERG potassium ion channels expressed in human embryonic kidney 293 cells

  2016cites this paper
• Pharmacokinetics of hERG Channel Blocking Voacangine in Wistar Rats Applying a Validated LC-ESI-MS/MS Method

  2016cites this paper
• miRNAs Regulate hERG

  2016cites this paper
• ADMET Evaluation in Drug Discovery. 16. Predicting hERG Blockers by Combining Multiple Pharmacophores and Machine Learning Approaches.

  2016cites this paper
• hERG Channels: From Antitargets to Novel Targets for Cancer Therapy

  2016cites this paper
• hERGChannels : FromAntitargets toNovelTargets for Cancer Therapy

  2016cites this paper
• Reduced expression of voltage-gated Kv11.1 (hERG) K+ channels in aganglionic colon in Hirschsprung’s disease

  2015cites this paper
• What links BRAF to the heart function? new insights from the cardiotoxicity of BRAF inhibitors in cancer treatment

  2015cites this paper
• New Pyrimido-Indole Compound CD-160130 Preferentially Inhibits the KV11.1B Isoform and Produces Antileukemic Effects without Cardiotoxicity

  2015cites this paper
• A ligand-based virtual screening approach to identify small molecules as HERG channel activators.

  2015cites this paper
• Blocking the passage: C60 geometrically clogs K(+) channels.

  2015cites this paper
• HPLC-Based Activity Profiling for hERG Channel Inhibitors in the South African Medicinal Plant Galenia africana

  2015cites this paper
• Up‐regulation of miR‐21 and miR‐23a Contributes to As2O3‐induced hERG Channel Deficiency

  2015cites this paper
• Effects of Tannic Acid, Green Tea and Red Wine on hERG Channels Expressed in HEK293 Cells

  2015influential citation
• Fluorogenic Probe for the Human Ether-a-Go-Go-Related Gene Potassium Channel Imaging

  2015cites this paper
• Novel perspectives in cancer therapy: Targeting ion channels.

  2015cites this paper
• Human Ether-à-go-go Related Gene (hERG) Channel Blocking Aporphine Alkaloids from Lotus Leaves and Their Quantitative Analysis in Dietary Weight Loss Supplements.

  2015cites this paper
• Kinetic studies of the Kv11.1 (hERG) channel

  2015cites this paper
• HERG-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs.

  2014cites this paper
• Insight into the molecular interaction between the cyclic nucleotide‐binding homology domain and the eag domain of the hERG channel

  2014influential citation
• The Activation Effect of Hainantoxin-I, a Peptide Toxin from the Chinese Spider, Ornithoctonus hainana, on Intermediate-Conductance Ca2+-Activated K+ Channels

  2014cites this paper
• The rescuable function and mechanism of resveratrol on As2O3-induced hERG K+ channel deficiency

  2014cites this paper
• Computational Methods in Biophysics and Medicinal Chemistry: Applications and Challenges

  2014cites this paper
• Drug-Induced Conformational Population Shifts in Topoisomerase-DNA Ternary Complexes

  2014cites this paper
• Dipeptidil peptidasa IV: inhibidores y sus potenciales aplicaciones biomédicas / Dipeptidil peptidase IV: inhibitors and potentials biomedical applications

  2014influential citation
• Exploration of 3-Aminoazetidines as Triple Reuptake Inhibitors by Bioisosteric Modification of 3-α-Oxyazetidine.

  2014cites this paper
• UNIVERSITY OF LJUBLJANA FACULTY OF PHARMACY IVA HARI OPTIMIZACIJA STRUKTURNO ODVISNIH PARAMETROV PRI SKLOPLJENI MASNI SPEKTROMETRIJI ZA IZBRANE SINTEZNE KANABINOIDE TER NJIHOVA MODULACIJA IONSKIH KANALOV OPTIMISATION OF COMPOUND-DEPENDENT PARAMETERS IN THE TANDEM MASS SPECTROMETRY FOR SELECTED SYNTH

  2014cites this paper
• Structural insight into the transmembrane segments 3 and 4 of the hERG potassium channel

  2014cites this paper
• Up-Regulation of hERG K+ Channels by B-RAF

  2014cites this paper
• Widened QRS interval and left ventricular systolic depression after propafenone and promazine exposure.

  2014cites this paper
• Arrhythmogenic effect of a crude extract from sea anemone Condylactis gigantea: possible involvement of rErg1 channels.

  2013cites this paper